Clinical Trial Update: Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic Retinopathy [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating intravitreal bevacizumab as part of surgical treatment for severe proliferative diabetic retinopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: University of Campania Luigi Vanvitelli | Conditions: Proliferative Diabetic Retinopathy | Phase 4 | Status: COMPLETED